Sanjay Shukla - 18 May 2021 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role
President and CEO, Director
Signature
Nancy Denyes, Attorney-in-Fact
Issuer symbol
ATYR
Transactions as of
18 May 2021
Net transactions value
+$40,100
Form type
4
Filing time
20 May 2021, 08:52:34 UTC
Next filing
25 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $40,100 +10,000 +121% $4.01 18,298 18 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents weighted average price for the shares. The shares were purchased at prices ranging from $3.99 to $4.04 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.